Literature DB >> 8468448

Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues.

N Kimura1, A Mizokami, T Oonuma, H Sasano, H Nagura.   

Abstract

We investigated the immunohistochemical localization of androgen receptor (AR) using a polyclonal antibody for 55 KD recombinant human AR in human tissues fixed with 4% paraformaldehyde solution and embedded in paraffin. Immunoreactive AR was restricted to the nuclei of various tissues. Among the well-known androgen target organs, secretory cells and basal cells of the prostate, spermatogonia, spermatocytes, Sertoli cells and Leydig cells of the testis, epithelial cells of the rete testis, fibroblasts in the whole organ, squamous cells, sweat gland and hair follicle cells of the skin, and hepatocytes of the liver were positive for AR. In addition, smooth muscle cells of the prostate, uterus, urinary bladder, gastrointestinal tract, arteries, and arterioles were strongly immunoreactive for AR. Cardiac muscle and striated muscle of psoas were positive for AR. Acinar cells, ductal cells, and myoepithelial cells of the breast, endocervical and endometrial cells of the uterus, cyto- and syncytiotrophoblast of the chorionic villi, and tubules of the kidney were also positive for AR. Most FSH, LH, and some GH endocrine cells in the anterior and posterior lobes of the pituitary gland, follicular cells of the thyroid gland, and adrenocortical cells were positive for AR. Cells immunoreactive for AR were ubiquitously distributed throughout the entire body. The present study demonstrated the diversity of androgen effects on many target tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8468448     DOI: 10.1177/41.5.8468448

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  47 in total

1.  Androgen receptor (AR), estrogen receptor-alpha (ER-alpha) and estrogen receptor-beta (ER-beta) expression in the testis of the newt, Triturus marmoratus marmoratus during the annual cycle.

Authors:  M I Arenas; M Royuela; M V Lobo; J M Alfaro; B Fraile; R Paniagua
Journal:  J Anat       Date:  2001-10       Impact factor: 2.610

2.  FHL2, a novel tissue-specific coactivator of the androgen receptor.

Authors:  J M Müller; U Isele; E Metzger; A Rempel; M Moser; A Pscherer; T Breyer; C Holubarsch; R Buettner; R Schüle
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

Review 3.  Endocrine control of spermatogenesis: Role of FSH and LH/ testosterone.

Authors:  Suresh Ramaswamy; Gerhard F Weinbauer
Journal:  Spermatogenesis       Date:  2015-01-26

4.  Monoclonal anti-androgen receptor antibodies: production, characterization and potential diagnostic applications.

Authors:  C C Shih; W J Young; C H Wang; L P Jin; X D Ji; Q Guan; M Wang; C Chang
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

5.  A population pharmacokinetic analysis of the oral CYP17 lyase and androgen receptor inhibitor seviteronel in patients with advanced/metastatic castration-resistant prostate cancer or breast cancer.

Authors:  Cody J Peer; Keith T Schmidt; Jessica D Kindrick; Joel R Eisner; Victoria V Brown; Edwina Baskin-Bey; Ravi Madan; William D Figg
Journal:  Cancer Chemother Pharmacol       Date:  2019-07-31       Impact factor: 3.333

Review 6.  Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice.

Authors:  Ruey-Sheng Wang; Shuyuan Yeh; Chii-Ruey Tzeng; Chawnshang Chang
Journal:  Endocr Rev       Date:  2009-01-27       Impact factor: 19.871

7.  Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma.

Authors:  Cristina Riva; Emanuele Dainese; Giacomo Caprara; Paolo Cossu Rocca; Giovanni Massarelli; Tibor Tot; Carlo Capella; Vincenzo Eusebi
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

8.  Association between CNDP1 genotype and diabetic nephropathy is sex specific.

Authors:  Antien L Mooyaart; Ana Zutinic; Stephan J L Bakker; Diana C Grootendorst; Nanne Kleefstra; Irene G M van Valkengoed; Stefan Böhringer; Henk J G Bilo; Friedo W Dekker; Jan Anthonie Bruijn; Gerjan Navis; Bart Janssen; Hans J Baelde; Emile De Heer
Journal:  Diabetes       Date:  2010-03-23       Impact factor: 9.461

9.  Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element.

Authors:  Marilena Lanzino; Diego Sisci; Catia Morelli; Cecilia Garofalo; Stefania Catalano; Ivan Casaburi; Claudia Capparelli; Cinzia Giordano; Francesca Giordano; Marcello Maggiolini; Sebastiano Andò
Journal:  Nucleic Acids Res       Date:  2010-04-26       Impact factor: 16.971

10.  Subfertile female androgen receptor knockout mice exhibit defects in neuroendocrine signaling, intraovarian function, and uterine development but not uterine function.

Authors:  K A Walters; K J McTavish; M G Seneviratne; M Jimenez; A C McMahon; C M Allan; L A Salamonsen; D J Handelsman
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.